Quinlog, Raycel A.

HRN: 21-45-91  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/10/2022
CEFUROXIME 750MG (VIAL)
06/10/2022
06/16/2022
IV
750mg
Q8h
Uti; Molar Pregnancy
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Urinary TractReproductive Tract    Compliance to guidelines: Non-compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: No  Wrong Duration  Wrong Duration

Overall appropriateness: No  Wrong Duration

Intervention



Type of Intervention done:

                    

           


Acceptance: